RESMED INC
stock AU:RMD (SYDNEY)

Alternative ID: AU000000RMD6

Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Exchange: SYDNEY
Sector: Healthcare
Industry: Health Care Equipment & Services
Market Cap: Large (47.93B)
Data in AUD

EPS: 1.01
Current PE: 218.83
BVPS: 5,735.07
Price/BVPS: 0.04
Dividend: 1.56 / 4.7%

Hist Grade: D (37.05)
YOY Grade: D (38.61)
Debt/FCF: 3.54
ROIC: 17.6%
PEG: 11.72
PEGY: 9.36

Value Price: 30.93
MOS Price: 15.47
MOS %: -86.1%
Graham Number: 360.70
Graham MOS %: 62.5%
IRT: 24.58

Market Price

222.00

-0.12 -0.1%

as of Jun 06 '23

52 Week Range:

27.83 243.52

Stock Analyzer Tutorials

General Info

type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

Financial Statements

type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

Growth Grade and Financial Ratios

type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

Price Charts

type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Exchange: SYDNEY
Sector: Healthcare
Industry: Health Care Equipment & Services
Market Cap: Large (47.93B)
Inst. Ownership: 8.37%
Insider Ownership: 0.00%
Full Time Employees: 8160

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement

Cash Flow Statement

Balance Sheet

Liquidity Ratios

Current Ratio

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name	Jun '12	Jun '13	Jun '14	Jun '15	Jun '16	Jun '17	Jun '18	Jun '19	Jun '20	Jun '21	Jun '22
Equity (BVPS)	1.13	1.34	1.28	1.43	1.59	1.70	1.97	2.01	2.27	2.48
growth rate		18.6%	-4.5%	11.7%	11.2%	6.9%	15.9%	2.0%	12.9%	9.3%
Earnings BIT	378.46	439.08	411.41	409.24	435.87	456.73	560.26	635.99	809.06	917.58	1,000.29
growth rate		16.0%	-6.3%	-0.5%	6.5%	4.8%	22.7%	13.5%	27.2%	13.4%	9.0%
Avg.PE	18.05	22.12	21.55	30.28	36.63	41.36	67.17	67.82	58.69	38.63	34.19
growth rate		22.6%	-2.6%	40.5%	21.0%	12.9%	62.4%	1.0%	-13.5%	-34.2%	-11.5%
ROA	12.12	14.13	15.10	15.53	12.95	10.18	9.66	11.28	14.30	10.19
growth rate		16.6%	6.9%	2.9%	-16.6%	-21.4%	-5.1%	16.8%	26.8%	-28.7%
ROE	15.27	19.09	20.50	21.10	21.47	18.73	15.70	19.59	27.21	17.63
growth rate		25.0%	7.4%	2.9%	1.8%	-12.8%	-16.2%	24.8%	38.9%	-35.2%
ROIC	12.60	14.92	16.38	17.04	13.76	12.53	11.98	15.17	18.35	13.16
growth rate		18.4%	9.8%	4.0%	-19.3%	-8.9%	-4.4%	26.6%	21.0%	-28.3%
Cur. Ratio	5.38	2.52	5.77	5.40	2.22	4.57	2.08	2.06	2.53	1.73
growth rate		-53.2%	129.0%	-6.4%	-58.9%	105.9%	-54.5%	-1.0%	22.8%	-31.6%
Quick Ratio	4.33	2.10	4.75	4.04	1.74	3.53	1.32	1.22	1.56	1.00
growth rate		-51.5%	126.2%	-15.0%	-56.9%	102.9%	-62.6%	-7.6%	27.9%	-35.9%
Leverage	1.33	1.37	1.34	1.38	1.92	1.77	1.49	1.98	1.84	1.64
growth rate		3.0%	-2.2%	3.0%	39.1%	-7.8%	-15.8%	32.9%	-7.1%	-10.9%
Balance Sheet	Jun '12	Jun '13	Jun '14	Jun '15	Jun '16	Jun '17	Jun '18	Jun '19	Jun '20	Jun '21	Jun '22
Acct.Receivable	322.88	362.89	359.59	362.57	382.09	450.53	497.02	538.32	484.10	625.19	601.64
growth rate		12.4%	-0.9%	0.8%	5.4%	17.9%	10.3%	8.3%	-10.1%	29.2%	-3.8%
Acct.Payable			85.41	81.11	92.57	92.76	92.72	115.73	135.79	138.01	159.25
growth rate				-5.0%	14.1%	0.2%	0.0%	24.8%	17.3%	1.6%	15.4%
Cur.Assets	1,551.90	1,651.78	1,556.21	1,407.84	1,419.72	1,644.00	1,065.72	1,145.37	1,523.46	1,574.76	1,931.48
growth rate		6.4%	-5.8%	-9.5%	0.8%	15.8%	-35.2%	7.5%	33.0%	3.4%	22.7%
Total Assets	2,437.42	2,520.42	2,360.96	2,181.77	3,256.71	3,468.49	3,063.92	4,107.68	4,587.38	4,728.13	5,095.85
growth rate		3.4%	-6.3%	-7.6%	49.3%	6.5%	-11.7%	34.1%	11.7%	3.1%	7.8%
Cash	922.91	998.73	905.73	717.25	731.43	821.94	188.70	147.13	463.16	295.28	273.71
growth rate		8.2%	-9.3%	-20.8%	2.0%	12.4%	-77.0%	-22.0%	214.8%	-36.3%	-7.3%
Inventory	198.83	166.23	165.42	246.86	224.46	268.32	268.70	349.64	416.92	457.03	743.91
growth rate		-16.4%	-0.5%	49.2%	-9.1%	19.5%	0.1%	30.1%	19.2%	9.6%	62.8%
Cur.Liabilities	288.33	654.42	269.56	266.46	637.99	360.13	511.25	555.99	602.76	911.77	689.30
growth rate		127.0%	-58.8%	-1.2%	139.4%	-43.6%	42.0%	8.8%	8.4%	51.3%	-24.4%
Liabilities	604.48	684.29	602.71	594.47	1,561.87	1,508.22	1,004.94	2,035.49	2,090.35	1,842.45	1,735.10
growth rate		13.2%	-11.9%	-1.4%	162.7%	-3.4%	-33.4%	102.6%	2.7%	-11.9%	-5.8%
LT Debt	285.94	0.91	300.77	300.59	873.33	1,078.61	269.99	1,258.86	1,164.13	643.35	765.33
growth rate		-99.7%	32,875.6%	-0.1%	190.5%	23.5%	-75.0%	366.3%	-7.5%	-44.7%	19.0%
Equity	1,832.82	1,836.13	1,758.25	1,587.31	1,694.83	1,960.27	2,058.98	2,072.19	2,497.03	2,885.68	3,360.75
growth rate		0.2%	-4.2%	-9.7%	6.8%	15.7%	5.0%	0.6%	20.5%	15.6%	16.5%
Common Shares	1,493.00	1,464.00	1,444.00	1,427.00	1,417.00	1,425.00	0.57	0.58	0.58	0.58	0.59
growth rate		-1.9%	-1.4%	-1.2%	-0.7%	0.6%	-100.0%	0.7%	0.9%	0.5%	0.5%
Cash Flow Statement	Jun '12	Jun '13	Jun '14	Jun '15	Jun '16	Jun '17	Jun '18	Jun '19	Jun '20	Jun '21	Jun '22
Capital Expenditures	53.70	72.51	72.72	62.50	58.53	62.22	62.58	68.71	95.33	102.71	134.84
growth rate		35.0%	0.3%	-14.1%	-6.4%	6.3%	0.6%	9.8%	38.7%	7.7%	31.3%
Cash Dividends	0.00	110.82	141.52	157.26	168.13	186.35	199.50	211.71	225.09	226.71	245.34
growth rate			27.7%	11.1%	6.9%	10.8%	7.1%	6.1%	6.3%	0.7%	8.2%
Cash From OA	436.89	459.23	391.27	383.18	547.93	414.05	505.03	459.05	802.26	736.72	351.15
growth rate		5.1%	-14.8%	-2.1%	43.0%	-24.4%	22.0%	-9.1%	74.8%	-8.2%	-52.3%
FCF per Share	0.19	0.23	0.24	0.29	0.40	0.32	0.42	0.37	0.51	0.67
growth rate		21.1%	4.4%	20.8%	37.9%	-20.0%	31.3%	-11.9%	37.8%	31.4%
Sale Purchase of Stock			33.35	38.81	27.69	30.16	23.33
growth rate				16.4%	-28.6%	8.9%	-22.6%
FCF	322.00	331.00	310.00	311.00	480.00	343.00	434.00	382.00	696.00	620.00	216.31
growth rate		2.8%	-6.3%	0.3%	54.3%	-28.5%	26.5%	-12.0%	82.2%	-10.9%	-65.1%
Income Statement	Jun '12	Jun '13	Jun '14	Jun '15	Jun '16	Jun '17	Jun '18	Jun '19	Jun '20	Jun '21	Jun '22
Sales	1,560.23	1,726.68	1,554.97	1,678.91	1,838.71	2,066.74	2,340.20	2,606.57	2,957.01	3,196.83	3,578.13
growth rate		10.7%	-9.9%	8.0%	9.5%	12.4%	13.2%	11.4%	13.4%	8.1%	11.9%
Op.Income	335.65	404.51	411.41	409.24	435.87	456.73	560.26	635.99	809.06	917.58	1,000.29
growth rate		20.5%	1.7%	-0.5%	6.5%	4.8%	22.7%	13.5%	27.2%	13.4%	9.0%
IBT	378.40	439.05	431.08	435.92	439.57	418.74	521.31	518.85	733.09	883.66	960.48
growth rate		16.0%	-1.8%	1.1%	0.8%	-4.7%	24.5%	-0.5%	41.3%	20.5%	8.7%
Net Income	290.61	350.12	345.27	352.89	352.41	342.28	315.59	404.59	621.67	474.51	779.44
growth rate		20.5%	-1.4%	2.2%	-0.1%	-2.9%	-7.8%	28.2%	53.7%	-23.7%	64.3%
EPS	0.17	0.21	0.23	0.24	0.24	0.24	0.22	0.28	0.42	0.32
growth rate		23.5%	9.5%	4.4%	0.0%	0.0%	-8.3%	27.3%	50.0%	-23.8%
Gross Profit	935.68	1,072.49	989.79	1,011.40	1,066.50	1,201.75	1,362.16	1,536.59	1,767.39	1,889.46	2,063.96
growth rate		14.6%	-7.7%	2.2%	5.5%	12.7%	13.4%	12.8%	15.0%	6.9%	9.2%
R&D	125.07	165.20	118.23	114.87	118.65	144.47	155.15	180.65	201.95	225.28	253.58
growth rate		32.1%	-28.4%	-2.8%	3.3%	21.8%	7.4%	16.4%	11.8%	11.6%	12.6%

Quarterly Statements

Item Name	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Earnings BIT	241.64	261.91	248.71	234.27	255.40
growth rate		8.4%	-5.0%	-5.8%	9.0%
Balance Sheet	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Acct.Receivable	625.19	601.35	550.72	534.23	601.64
growth rate		-3.8%	-8.4%	-3.0%	12.6%
Acct.Payable	138.01	173.70	163.37	149.80	159.25
growth rate		25.9%	-6.0%	-8.3%	6.3%
Cur.Assets	1,574.76	1,586.26	1,547.24	1,704.30	1,931.48
growth rate		0.7%	-2.5%	10.2%	13.3%
Total Assets	4,728.13	4,729.17	4,734.74	4,905.26	5,095.85
growth rate		0.0%	0.1%	3.6%	3.9%
Cash	295.28	276.15	194.48	201.77	273.71
growth rate		-6.5%	-29.6%	3.8%	35.7%
Inventory	457.03	506.64	592.15	664.94	743.91
growth rate		10.9%	16.9%	12.3%	11.9%
Cur.Liabilities	911.77	624.16	621.06	667.27	689.30
growth rate		-31.5%	-0.5%	7.4%	3.3%
Liabilities	1,842.45	1,703.12	1,588.91	1,626.46	1,735.10
growth rate		-7.6%	-6.7%	2.4%	6.7%
LT Debt	643.35	793.67	667.98	668.74	765.33
growth rate		23.4%	-15.8%	0.1%	14.4%
Equity	2,885.68	3,026.05	3,145.84	3,278.80	3,360.75
growth rate		4.9%	4.0%	4.2%	2.5%
Common Shares	0.58	0.58	0.59	0.59	0.59
growth rate		0.0%	0.3%	0.0%	0.2%
Cash Flow Statement	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Capital Expenditures	27.91	27.34	30.41	48.45	28.64
growth rate		-2.0%	11.2%	59.3%	-40.9%
Cash Dividends	56.80	61.19	61.25	61.42	61.49
growth rate		7.7%	0.1%	0.3%	0.1%
Cash From OA	226.53	-65.66	219.88	117.44	79.49
growth rate		-100.0%	100.0%	-46.6%	-32.3%
Sale Purchase of Stock
growth rate
FCF	198.62	-93.00	189.47	68.99	50.84
growth rate		-100.0%	100.0%	-63.6%	-26.3%
Income Statement	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Sales	876.10	904.02	894.87	864.50	914.74
growth rate		3.2%	-1.0%	-3.4%	5.8%
Op.Income	241.64	261.91	248.71	234.27	255.40
growth rate		8.4%	-5.0%	-5.8%	9.0%
IBT	239.21	258.79	237.29	226.32	238.09
growth rate		8.2%	-8.3%	-4.6%	5.2%
Net Income	195.10	203.61	201.75	179.01	195.06
growth rate		4.4%	-0.9%	-11.3%	9.0%
EPS
growth rate
Gross Profit	501.76	517.35	515.55	502.18	528.89
growth rate		3.1%	-0.4%	-2.6%	5.3%
R&D	59.88	59.95	62.51	66.80	64.32
growth rate		0.1%	4.3%	6.9%	-3.7%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (37.05)

YOY Growth Grade:

D (38.61)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Dividend Yield: 4.7%
Beta: 0.48
Beta of 0.4794 suggests that the asset is less volatile than the rest of the market.
PE: 218.83
EY: 0.5%
PEG: 11.72
PEG Ratio of 11.72 suggests that stock is overpriced.
PEGY: 9.36
PEGY Ratio of 9.36 suggests that stock is overpriced.
Price/BVPS: 0.04
Price to BVPS Ratio of 0.04 suggests that stock is undervalued.

Profitability Ratios

ROE: 17.6%
Return on Equity (ROE) of 17.6% suggests that a company is doing well.
ROS: 28.0%
The value of Return on Sales depends on the business and/or industry. Usually the higher ratio the better.
ROA: 18.9%
Return on Assets (ROA). Low ratio usually means poor performance, or ineffective use of assets by management. High ratio usually means good performance.
ROI: 28.6%
Return on Investment (ROI) of 28.6% suggests that a company is doing well.
ROIC: 17.6%
Return on Invested Capital (ROIC) of 17.6% suggests that a company is doing well.

Liquidity Ratios

Current Ratio: 2.80
Current Ratio of 2.80 suggests that money that could be working for the business is tied up in government securities, cash savings or other safe funds.
Quick Ratio: 1.27
Quick Ratio of 1.27 suggests that a company is doing well.
Cash Turnover: 2.88
Turnover Of Cash Ratio of 2.88 suggests that a company may have funds tied up in short-term low-yielding assets or may have a cash surplus, which is not invested in the business.
Equity Ratio: 66.0%
Equity Ratio of 66.0% suggests that a large percent of the company's assets financed by shareholder equity, which is good.
Debt/Equity: 51.6%
Debt to Equity Ratio of 51.6% suggests that a company is doing well.
Debt/FCF: 3.54
Debt/FCF of 3.54 suggests that a company does not have enough cash to pay off its long term debt within three years.

Efficiency Ratios

Avg Collection Period: 61.37
Average Collection Period of 61.37 days suggests a slow turnover, which may be the result of a number of bad accounts, or a tax collection policy or perhaps credit is being used to generate sales.
Inventory Turnover: 2.04
Inventory Turnover Ratio of 2.04 suggests a large inventory, a never-out-of-stock situation, perhaps some obsolete items, or it could indicate poor liquidity and possible overstocking of items.
Cash Flow Ratio: 8.45
Cash Flow Ratio of 8.45 suggests a company is doing OK, but lower inventory is generally viewed as a positive trend.
Profit Margin: 21.8%

Value Price

PE and EPS

	Historical	Current	Forward
PE	32.39	220.18	32.99
EPS / Growth	13.4%	1.01	18.7%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 11.9%

Estimates	Pessimistic	Moderate	Optimistic
Rate of Return	15.0%
MOS Price %	50 %
Future EPS Growth	11.9%	14.7%	14.7%
Future PE	23.88	31.57	31.57
Future EPS	3.11	3.96	3.96
Value Price MOS %	18.39 -91.7%	30.93 -86.1%	30.93 -86.1%
MOS Price	9.19	15.47	15.47
IRT	28.34	24.63	24.63

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Graham Number: 360.70
Graham MOS: 62.5%

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.